Prognostic Significance of CSF-1R Expression in Early Invasive Breast Cancer

Código QR

Prognostic Significance of CSF-1R Expression in Early Invasive Breast Cancer

Colony-stimulating factor-1 receptor (CSF-1R) signaling promotes an immune suppressive microenvironment enriched in M2 macrophages. Given that CSF-1R inhibitors are under investigation in clinical trials, including in breast cancer, CSF-1R expression and association with immune biomarkers could iden...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Nazia Riaz, Samantha Burugu, Angela S. Cheng, Samuel C. Y. Leung, Dongxia Gao, Torsten O. Nielsen
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	colony-stimulating factor-1 receptor immunohistochemistry prognosis estrogen receptor-positive breast cancer invasive breast cancer immune check points Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/abeea43bae854238ba522f7fc6b26fb2
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Intracellular aggregated TRPV1 is associated with lower survival in breast cancer patients
por: Lozano C, et al.
Publicado: (2018)

Survival rates of advanced estrogen-receptor positive breast cancer. Analysis of 211 cases
por: Sánchez,César, et al.
Publicado: (2020)

NOTTINGHAM PROGNOSTIC INDEX IN DIFFERENT AGE GROUPS OF NEWLY DIAGNOSED BREAST CARCINOMA PATIENTS AND ITS ASSOCIATION WITH ER, PR AND HER-2-NEU RECEPTOR STATUS
por: Faryal Zafar, et al.
Publicado: (2019)

Neighborhood disadvantage and individual-level life stressors in relation to breast cancer incidence in US Black women
por: Lauren E. Barber, et al.
Publicado: (2021)

Terapia endocrina neoadyuvante en cáncer de mama, una alternativa de tratamiento e investigación
por: Acevedo,Francisco, et al.
Publicado: (2013)

Application of preoperative ultrasound features combined with clinical factors in predicting HER2-positive subtype (non-luminal) breast cancer
por: Jin Zhou, et al.
Publicado: (2021)

Estrogen Receptors in Immunohistochemically Stained Slides: Comparing Subjective and Computerized Evaluation Methods
por: Millas,Ieda, et al.
Publicado: (2014)

Discordance of the estrogen receptor and HER-2/neu in breast cancer from primary lesion to first and second metastatic site
por: Lower EE, et al.
Publicado: (2017)

Prognostic Significance of Estrogen Receptor Alpha in Oral Squamous Cell Carcinoma
por: Christian Doll, et al.
Publicado: (2021)

Estrogen receptor variant ERα46 and insulin receptor drive in primary breast cancer cells growth effects and interleukin 11 induction prompting the motility of cancer‐associated fibroblasts
por: Francesca Cirillo, et al.
Publicado: (2021)

Discovery of a novel potentially transforming somatic mutation in CSF2RB gene in breast cancer
por: Mamoon Rashid, et al.
Publicado: (2021)

Inmunohistochemical Evaluation of Estrogen Receptors Alpha and Beta in Normal Inferior Turbinate Mucosa
por: Millas,Ieda, et al.
Publicado: (2010)

Breast Cancer and Tamoxifen: A Nigerian Perspective to Effective Personalised Therapy
por: Adehin A, et al.
Publicado: (2020)

ANALYSIS OF ESTROGEN RECEPTOR (ER) AND PROGESTRONE RECEPTOR (PR) EXPRESSION IN SURFACE EPITHELIAL TUMORS OF OVARY AND ITS CORRELATION WITH THEIR CLINICAL STAGE
por: Madeeha Anwar, et al.
Publicado: (2018)

Analyzing the Estrogen Receptor Status of Liver Metastases with [<sup>18</sup>F]-FES-PET in Patients with Breast Cancer
por: Jorianne Boers, et al.
Publicado: (2021)

Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-α-positive breast cancer
por: Casneuf T, et al.
Publicado: (2016)

Protein expression profile and microRNA expression signature in estrogen receptor-positive and -negative breast cancers: report of two cases
por: Tsunoda Y, et al.
Publicado: (2018)

Positive Regulation of Estrogen Receptor Alpha in Breast Tumorigenesis
por: Lucas Porras, et al.
Publicado: (2021)

PGRMC1 Promotes Progestin-Dependent Proliferation of Breast Cancer Cells by Binding Prohibitins Resulting in Activation of ERα Signaling
por: Yingxue Bai, et al.
Publicado: (2021)

Tumor suppressor ING4 inhibits estrogen receptor activity in breast cancer cells
por: Keenen MM, et al.
Publicado: (2016)

Preparation, Characterization, and Pharmacokinetic Study of a Novel Long-Acting Targeted Paclitaxel Liposome with Antitumor Activity
por: Han B, et al.
Publicado: (2020)

PI3Kinase Inhibition in Hormone Receptor-Positive Breast Cancer
por: Ajay Dhakal, et al.
Publicado: (2021)

Association of Endocrine Therapy and Dementia in Women with Breast Cancer
por: Thompson MR, et al.
Publicado: (2021)

Prognostic and clinicopathological values of tissue expression of MFAP5 and ITM2A in triple-negative breast cancer: an immunohistochemical study
por: Abdulwahab Abuderman, et al.
Publicado: (2020)

Novel Mechanisms of Tumor Promotion by the Insulin Receptor Isoform A in Triple-Negative Breast Cancer Cells
por: Veronica Vella, et al.
Publicado: (2021)

ASSOCIATION OF HORMONE RECEPTORS WITH RISK FACTORS AMONG BREAST CANCER PATIENTS
por: Ummara Aslam, et al.
Publicado: (2021)

In vivo and in vitro estrogenic and progestagenic actions of Tibolone
por: SADARANGANI,ANIL, et al.
Publicado: (2005)

A novel hydrazide compound exerts anti-metastatic effect against breast cancer
por: Dehghani,Soudeh, et al.
Publicado: (2019)

Proteolysis-targeting chimeras and their implications in breast cancer
por: Angeles C. Tecalco-Cruz, et al.
Publicado: (2021)

Identification of LIG1 and LIG3 as prognostic biomarkers in breast cancer
por: Sun Lin, et al.
Publicado: (2021)

Pharmacologic management of bone-related complications and bone metastases in postmenopausal women with hormone receptor-positive breast cancer
por: Yardley DA
Publicado: (2016)

Programmed Death-Ligand 1 Expression in Breast Cancer Patients: Clinicopathological Associations from a Single-Institution Study
por: Ayoub NM, et al.
Publicado: (2021)

Variable Expression of the Disialoganglioside GD2 in Breast Cancer Molecular Subtypes
por: Ramona Erber, et al.
Publicado: (2021)

Diagnostic Performance of [<sup>18</sup>F]FDG PET in Staging Grade 1–2, Estrogen Receptor Positive Breast Cancer
por: Ramsha Iqbal, et al.
Publicado: (2021)

Evaluating the Risk of Breast Cancer Recurrence and Metastasis After Adjuvant Tamoxifen Therapy by Integrating Polymorphisms in Cytochrome P450 Genes and Clinicopathological Characteristics
por: Hui Pang, et al.
Publicado: (2021)

IMMUNOHISTOCHEMICAL EXPRESSION OF ANDROGEN RECEPTOR IN TRIPLE NEGATIVE BREAST CARCINOMA AT ARMED FORCES INSTITUTE OF PATHOLOGY, RAWALPINDI
por: Amna Ameer, et al.
Publicado: (2021)

Factors affecting local recurrence and distant metastases of invasive breast cancer after breast-conserving surgery in Chiang Mai University Hospital
por: Ditsatham C, et al.
Publicado: (2016)

High Pregnane X Receptor (PXR) Expression Is Correlated with Poor Prognosis in Invasive Breast Carcinoma
por: Stamatios Theocharis, et al.
Publicado: (2021)

The relationship of GITR, Lag-3 and PD-1 expression with the main indicators of systemic and local immunity in patients with breast cancer
por: Dmitrii V. Tabakov, et al.
Publicado: (2021)

Dietary Factors and Breast Cancer Prognosis among Breast Cancer Survivors: A Systematic Review and Meta-Analysis of Cohort Studies
por: Sin-Hye Park, et al.
Publicado: (2021)